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OBJECTIVE—Patients with diabetes are at an increased risk
for developing corneal complications and delayed wound heal-
ing. This study investigated the effects of high glucose on
epidermal growth factor receptor (EGFR) signaling and on
epithelial wound healing in the cornea.
RESEARCH DESIGN AND METHODS—Effects of high glu-
cose on wound healing and on EGFR signaling were investigated
in cultured porcine corneas, human corneal epithelial cells, and
human corneas using Western blotting and immunoﬂuorescence.
Effects of high glucose on reactive oxygen species (ROS) and
glutathione levels and on EGFR pathways were assessed in
porcine and primary human corneal epithelial cells, respectively.
The effects of EGFR ligands and antioxidants on high glucose–
delayed epithelial wound healing were assessed in cultured
porcine corneas.
RESULTS—High glucose impaired ex vivo epithelial wound
healing and disturbed cell responses and EGFR signaling to
wounding. High glucose suppressed Akt phosphorylation in an
ROS-sensitive manner and decreased intracellular glutathione in
cultured porcine corneas. Exposure to high glucose for 24 h
resulted in an increase in ROS-positive cells in primary human
corneal epithelial cells. Whereas heparin-binding EGF-like
growth factor and antioxidant N-acetylcysteine had beneﬁcial
effects on epithelial wound closure, their combination signiﬁ-
cantly accelerated high glucose–delayed wound healing to a level
similar to that seen in control subjects. Finally, Akt signaling
pathway was perturbed in the epithelia of human diabetic
corneas, but not in the corneas of nondiabetic, age-matched
donors.
CONCLUSIONS—High glucose, likely through ROS, impairs the
EGFR–phosphatidylinositol 3-kinase/Akt pathway, resulting in
delayed corneal epithelial wound healing. Antioxidants in com-
bination with EGFR ligands may be promising potential thera-
peutics for diabetic keratopathy. Diabetes 58:1077–1085, 2009
W
ith a rapid increase in the prevalence of
diabetes, ocular complications have become
a leading cause of blindness in the world (1).
In addition to abnormalities of the retina
(diabetic retinopathy) and the lens (cataracts), various
types of corneal disorders are also relatively common in
diabetes patients (2). Abnormalities of the cornea include
alterations in the epithelial basement membrane, such as
thickening (3,4), decreased number of hemidesmosomes
(5), and deposition of advanced glycation end products
(3,6). For the epithelium, hyperglycemia signiﬁcantly al-
ters its structure and function, resulting in basal cell
degeneration (3,6–8), decreased (9) or increased (10) cell
proliferation, superﬁcial punctate keratitis (11), break-
down of barrier function (12), fragility (13), recurrent
erosions, and persistent epithelial defects (14), depending
on the duration of diabetes and on the serum concentra-
tion of A1C. The epithelial abnormalities, termed keratopa-
thy/epitheliopathy, are resistant to conventional treatment
regimens (15,16). Hence, a better understanding of the
pathogenesis of diabetic keratopathy should lead to a
better management of the disease.
Although the described keratopathy can be attributed in
part to defects in epithelium-basement membrane adhe-
sion and to corneal neuropathy (17,18), many epithelial
abnormalities may also be related to alterations in cell
signaling, particularly to epidermal growth factor (EGF)
receptor (EGFR)-mediated cell responses to environmen-
tal challenges. EGFR signaling is needed for controlling
the proliferation, differentiation, and survival of epithelial
cells (19). Known ligands for EGFR include EGF, heparin-
binding EGF-like growth factor (HB-EGF), and transform-
ing growth factor-. Analysis of EGFR-deﬁcient mice
revealed that the cell types most affected are epithelial and
glial cells, the same cell types where EGFR is found to be
overexpressed in human tumors (19,20). Interestingly,
targeting EGFR with cetuximab (an EGFR monoclonal
antibody) and Geﬁtinib/Iressa (an EGFR kinase inhibitor)
for cancer treatments resulted in ocular abnormalities in
some patients, including diffuse punctate keratitis and
corneal erosion (21,22), which were also frequently ob-
served in diabetic corneas. Thus, maintaining a proper
level of EGFR signaling is critical for the physiological
state of an epithelium in tissues, and long-term exposure
to hyperglycemia may inevitably affect EGFR signaling
apparatus, leading to cell dysfunction, including compro-
mised barrier function and delayed wound healing.
In the last few years, oxidative stress, resulting from
enhanced production of reactive oxygen species (ROS)
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to hyperglycemia, has been postulated as a unifying mech-
anism causing diabetic complications (23–25). In many
tissues, including retina and kidney, increased ROS pro-
duction is associated with the onset, progression, and
pathological consequences of diabetes (26,27). However,
whether hyperglycemia induces the generation of ROS and
causes epithelial cell damage and dysfunction in the
cornea has not been documented. The cornea’s visual
properties are exquisitely sensitive to the tissue damage
caused by oxidative stress. Because the transparent cor-
nea is frequently exposed to sunlight, including harmful
ultraviolet (UV) light, there is a strong defense mechanism
against UV-induced oxidative stress. However, severe tis-
sue damage has been observed in the corneas of diabetic
patients, especially those with diabetic retinopathy, which
serves as an indication of long-term hyperglycemia (7,28).
The characteristics of diabetic keratopathy implicate oxi-
dative stress–induced cell injury and dysfunction. Hence,
hyperglycemia may cause the oxidative stress, a result of
the generation of ROS and impairment of the intracellular
antioxidant defense system, in the cornea.
In this study, we tested the hypothesis that EGFR
signaling pathways in diabetic corneal epithelial cells are
impaired and that such alterations contribute to delayed
epithelial wound healing. Our results suggest that thera-
peutics containing antioxidants and EGFR ligands may be
effective in treating delayed wound healing in diabetic
corneas.
RESEARCH DESIGN AND METHODS
Culture media were purchased from Invitrogen (Grand Island, NY). Human
recombinant HB-EGF was obtained from R&D Systems (Minneapolis, MN).
N-acetylcysteine (NAC), L-buthionine sulfoximine (BSO), and 2, 7-dichlo-
roﬂuorescein (DCF) were from Sigma-Aldrich (St. Louis, MO). A glutathione
assay kit was purchased from Cayman Chemical (Ann Arbor, MI). Rabbit
anti-human EGFR, mouse anti-extracellular signal–regulated kinase 2 (ERK2)
and phospho (p)-ERK1/2 were from Santa Cruz Biotechnology (Santa Cruz,
CA). Rabbit anti-Akt, phospho (p)-Akt (ser
473), and phospho (p)-EGFR (Y
845
and Y
1068) were obtained from Cell Signaling (Danvers, MA).
Porcine corneal epithelial wounding and organ culture. Porcine eyes
were obtained from a local abattoir, transported to the laboratory on ice in a
moist chamber, and processed for corneal culture the same day. An epithelial
wound was made by demarcating an area on the central cornea with a 5-mm
trephine and then removing the epithelium within the circle with a small
scalpel, leaving an intact basement membrane (29). Corneal-scleral rims were
excised and rinsed in sterilized PBS (pH 7.4). The excised corneas were
placed epithelial side down into a sterile cup of silicon mold. The endothelial
corneal cavity was then ﬁlled with minimum essential medium (MEM)
containing 1% agarose and 1 mg/ml collagen maintained at 42°C. This mixture
was allowed to gel. The cornea, along with its supporting gel, was inverted and
transferred to a 35-mm dish. At that point, 2 ml of MEM was added
drop-wise to the surface of the central cornea until the limbal conjunctiva was
covered, leaving the epithelium exposed to the air. The corneas were then
cultured in a humidiﬁed 5% CO2 incubator at 37°C in MEM containing 5 mmol/l
(normal glucose), 25 mmol/l D-glucose (high glucose), or 5 mmol/l D-glucose
plus 20 mmol/l mannitol (high mannitol). The wound was allowed to heal for
48 h in MEM with or without HB-EGF (50 ng/ml) or NAC (25 mol/l). In our
preliminary study, we found that high NAC concentrations (50 mol/l)
caused an increase in opacity of cultured corneas, and as a result, 25 mol/l
was chosen for the study. After 48 h culture, the corneas were stained with
Richardson’s staining solution to mark the remaining wound area, photo-
graphed, and quantiﬁed using Photoshop software. At least four corneas were
used for each treatment, and two independent experiments were performed
(eight or more corneas for each treatment).
Measurement of intracellular glutathione. Porcine corneal epithelial cells,
collected 48 h postwounding, were lysed with radioimmunoprecipitation
assay (RIPA) buffer with a proteinase inhibitor cocktail, sonicated, and used
for determination of protein concentration by the micro-BCA (bicinchoninic
acid) method. Cell lysates containing 10 g of proteins were deproteinized
with 10% meta-phosphoric acid, and glutathione was measured in the resultant
supernatant by the glutathione assay kit. The concentration of glutathione was
obtained in reference to a standard curve.
Assessment of EGFR, ERK, and Akt phosphorylation ex vivo and in
vitro. To assess effects of high glucose on cell signaling ex vivo, porcine
corneal epithelial cells were isolated at the end of a 48-h organ culture, lysed
in RIPA buffer, and processed for Western blotting.
Primary human corneal epithelial cells (29) and an SV40-immortalized/
transformed human corneal epithelial cell line (THCE) (30) were cultured in
deﬁned keratinocyte serum-free medium containing normal or high glucose
for 48 h and starved overnight in keratinocyte basal medium with the same
glucose conditions. Cells on 100-mm dishes were wounded by multiple linear
scratches using a cut of 48-well shark tooth comb for DNA sequencing gel
(Bio-Rad, Hercules, CA) going from one side of the dish to the other. The dish
was then rotated, and scrapes were made similarly to the original scrapes at
45°, 90°, and 135°. At the indicated times, cells were lysed with RIPA buffer
and used for Western blotting. Cell lysate of 10–30 g proteins was used to
determine phosphatidylinositol (PI) 3-kinase and ERK activation using anti-
bodies against p-Akt and p-ERK1/2, respectively, with Akt and ERK2 levels for
equal protein loading. EGFR tyrosine phosphorylation in wounded THCE cells
was analyzed using antibodies against p-EGFR (Y
845 and Y
1068).
Immunohistochemical studies of human diabetic corneas. Normal and
diseased human autopsy corneas obtained from the NDRI (National Disease
Research Interchange, Philadelphia, PA) were embedded in OCT (Ted Pella,
Redding, CA) on arrival. The OCT blocks were immediately frozen in liquid
nitrogen and stored at 80°C. The cryostat sections were used from corneas
belonging to 10 diabetic patients (6 with type 1 diabetes, mean age 68.3  4.8
years, and 4 with non–insulin-dependent type 2 diabetes, mean age 75.0  7.5
years) and 4 patients without diabetes and eye disease (referred to as
normal healthy; mean age 69.4  4.6 years). The sections, usually three to
four in each slide, were stained either with rabbit antibodies against p-Akt
or with nonimmune rabbit IgG (negative control), and subsequently with
goat anti-rabbit ﬂuorescein-conjugated secondary antibody (Jackson Im-
monoResearch Lab, West Grove, PA). The slides were then washed in PBS
and mounted with Vectashield mounting medium containing 4,6-
diamidino-2-phenylindole (DAPI) nuclear staining and examined under a
Carl Zeiss Axioplan 2 ﬂuorescence microscope equipped with an ApoTome
digital camera. Negative controls (rabbit IgG isotypes) exhibited no
ﬂuorescence (data not shown).
Measurement of intracellular ROS. The level of intracellular ROS was
determined on the basis of the oxidative conversion of cell-permeable
2,7-dichloroﬂuorescein diacetate (DCFH-DA) to ﬂuorescent DCF on reaction
with hydroxyl radical, hydrogen peroxide, or peroxynitrite. Primary human
corneal epithelial cells at passage 3 were seeded onto 6-well plates. After cell
attachment and growth for 1 day, the cells were treated with normal glucose,
high mannitol, or high glucose in deﬁned keratinocyte SFM for 24 h. Cells
were then incubated with DCFH-DA (5 mol/l) in Hank’s balanced salt
solution in 37°C for 45 min in the dark, detached from culture wells by 0.05%
trypsin-EDTA, and washed twice with ice-cold PBS. Cells without DCFH-DA
were used as the negative control; cells treated with BSO (250 mol/l) to
deplete intracellular glutathione were used as the positive control. Flow
cytometric measurements (Becton Dickinson FACS DiVa cell sorter) were
performed in triplicate for each treatment. The mean ﬂuorescence intensity
was quantiﬁed by CELLQuest software.
The intracellular accumulation of ROS was also detected in THCE cells
plated on eight chamber slides cultured in normal glucose, high mannitol, or
high glucose with or without NAC for 24 h by the addition of DCFH-DA to the
culture. The distribution of ﬂuorescent DCF on the cell monolayer was
visualized under a ﬂuorescence microscope, and the pictures were taken
using a Spot digital camera.
Statistical analysis. Data were presented as the means  SD. Statistical
differences among three or more groups were identiﬁed using one-way
ANOVA. Differences were considered statistically signiﬁcant at P  0.05.
RESULTS
High glucose signiﬁcantly attenuates porcine corneal
epithelial wound healing. We previously used cultured
porcine corneas as an ex vivo model to study epithelial
wound healing, and this air/liquid corneal organ culture
model has been shown to preserve the structural integrity
and the responsiveness of epithelial cells to wounding and
growth factor stimulation (29,31,32). To assess whether
high glucose inﬂuences corneal epithelial wound healing,
we cultured porcine corneas in high glucose, using normal
glucose or high mannitol as controls. The epithelial wounds
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cornea and allowed to heal for 48 h. As shown in Fig. 1, a
5-mm epithelial wound was 75% covered in the corneas
cultured in normal glucose. Interestingly, high glucose
signiﬁcantly impaired epithelial wound closure in cultured
porcine corneas (only 29% of the wound was covered) in a
manner similar to that observed in cultured human dia-
betic corneas (8). Importantly, high glucose–induced delay
in epithelial wound healing was independent of osmotic
changes because 20 mmol/l D-mannitol had minimal effects
on the process. We concluded that high glucose impairs
corneal epithelial wound closure in cultured corneas.
High glucose decreases antioxidant abilities of
corneal epithelial cells in cultured porcine corneas.
Glutathione is a major intracellular free radical scavenger,
and its intracellular levels have been used as a parameter
to measure cellular antioxidant ability (33). We measured
the levels of intracellular glutathione in collected porcine
corneal epithelial cells. Cells cultured in high glucose for
48 h had signiﬁcantly reduced cellular glutathione concen-
tration (Fig. 2) compared with those cultured in normal
glucose or high mannitol.
High glucose targets PI 3-kinase/Akt pathways in
cultured porcine corneas. We previously showed that
wounding elicits EGFR-mediated ERK and PI 3-kinase/Akt
activation in corneal epithelial cells (29,34). To elucidate
the mechanism underlying high glucose–induced impair-
ment in wound closure, we next investigated the effects of
high glucose on EGFR signaling (Fig. 3). In the corneas
cultured in both normal and high glucose, wounding
stimulated the phosphorylation of ERK1/2. On the other
hand, whereas the level of p-Akt in the wounded corneas
cultured in normal glucose appeared to be higher than that
of the unwounded controls, the level of p-Akt, clearly
detectable, in the porcine corneal epithelial cells cultured
in high glucose with or without wounding was much lower
than in those cultured in normal glucose. The cellular
protein levels of Akt and ERK2 were largely the same in all
samples tested. Thus, high glucose appears to speciﬁcally
target PI 3-kinase/Akt in corneal epithelial cells.
Altered p-Akt staining in diabetic human corneal
epithelium. Having shown that the EGFR-mediated PI
3-kinase/Akt signaling pathway was altered in porcine
corneal epithelial cells cultured in high glucose, we then
investigated whether this pathway was also affected by
hyperglycemia in the corneas of patients with diabetes.
Figure 4 shows representative staining of p-Akt in each
diabetes category, within which a similar staining pattern
was observed: normal (four subjects), type 1 diabetic (six
FIG. 1. High glucose delays epithelial wound closure in cultured
porcine corneas. A corneal epithelial wound of 5-mm diameter was
made and allowed to heal for 48 h in MEM containing normal glucose
(NG; 5 mmol/l D-glucose), glucose plus mannitol (HM; 5 mmol/l D-
glucose plus 20 mmol/l mannitol), and high glucose (HG; 25 mmol/l
D-glucose). Wounded corneas were stained with Richardson solution to
show the remaining wound area at the end of the culture. A: These
ﬁgures are representatives of four corneas per condition from ﬁve
independent experiments. Scale bar: 5 mm. B: Remaining wound area
after 48 hours. Changes in the mean of the remaining wound areas in
pixels were calculated by Adobe Photoshop software. **P < 0.01. (A
high-quality digital representation of this ﬁgure is available in the
online issue.)
FIG. 2. High glucose decreases intracellular levels of reduced glutathi-
one (GSH) in porcine corneal epithelial cells. Porcine corneas with
epithelial debridement wounds were cultured as described in Fig. 1. At
the end of the culture, corneal epithelium was scraped off, lysed in
RIPA buffer, and sonicated. The glutathione was measured in cellular
supernatant using a glutathione assay kit, and the results were pre-
sented as nanomoles of total glutathione per microgram of cell extract
after normalization of glutathione reading with the total protein
content of each sample. Values are the means  SD of six corneas in
each group. *P < 0.05. HG, high glucose; HM, high mannitol; NG, normal
glucose.
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FIG. 3. Downregulation of PI 3-kinase/Akt pathways in porcine corneas
cultured in high glucose. Porcine corneas with (W) or without (N)
epithelial debridement wounds were cultured in normal glucose (NG; 5
mmol/l D-glucose) and high glucose (HG; 25 mmol/l D-glucose) and
allowed to heal for 48 h. At the end of the culture, corneal epithelium
was scraped off, lysed in RIPA buffer, and sonicated. Equal amounts of
cell lysates were immunoblotted with antibodies against p-Akt or
p-ERK1/2. The immunoreactivities were stripped off, and the same
membranes were reprobed with antibodies against cellular Akt or
ERK2, respectively, for proper protein loading.
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diabetic (diet controlled, one subject). In the basal layer of
the corneal epithelium of a normal subject (74 years old),
p-Akt staining was strong and continuous, consistent with
the metabolically active and proliferative characteristics
of the basal layer. A similar staining pattern of p-Akt was
noticed in the cornea of a patient with non–insulin-
dependent, diet-controlled diabetes (64 years old). How-
ever, in a patient with insulin-dependent type 1 diabetes
(63 years old with 54 years of diabetes), a few cells at the
basal layer were p-Akt–positive, and the staining pattern
was patchy and discontinuous. A similar pattern of p-Akt
staining was also observed in the cornea of a patient with
non–insulin-dependent type 2 diabetes (78 years old with 8
years of diabetes).
High glucose inﬂuences EGFR signaling in response
to wounding in THCE cells. To understand the effects
of elevated glucose on cell response to wounding, we
investigated EGFR signaling in THCE cells cultured in high
glucose. In cells cultured in both normal and high glucose,
wounding resulted in a rapid increase in the phosphoryla-
tion of ERK1/2 and Akt (Fig. 5). However, the intensity of
such activation in cells cultured in high glucose was much
reduced compared with cells cultured in normal glucose.
Furthermore, the activation of ERK and Akt in high
glucose was more transient, as indicated by phosphoryla-
tion levels that declined to a level similar to those of the
unwounded cells at 30 min postwounding versus 2 h
postwounding in cells cultured in normal glucose. The low
levels of ERK and PI 3-kinase/Akt activation in cells
cultured in high glucose appeared to be related to the
wound-induced EGFR activation because site-speciﬁc
phosphorylation of EGFR at Y
1068 and Y
845 declined more
quickly in cells cultured in high glucose than in normal
glucose. These results suggest that chronic exposure to
high glucose could blunt EGFR signaling and its down-
stream Akt and ERK activation in corneal epithelial cells.
High glucose increases the generation of ROS in
primary human corneal epithelial cells. To examine
whether high-glucose treatment induces ROS production,
we measured intracellular ROS levels in primary human
corneal epithelial cells using the redox-sensitive ﬂuores-
cent dye DCFH-DA and ﬂow cytometry. Figure 6A shows
that high glucose increased the number of cells with high
intensity of ﬂuorescence compared with cells cultured in
normal glucose or high mannitol. High glucose caused a
40.1% increase in ﬂuorescence intensity over that in nor-
mal glucose, indicating oxidative stress on high-glucose
treatment (Fig. 6B). High-glucose–induced generation of
ROS in cultured human corneal epithelial cells was con-
ﬁrmed by ﬂuorescent microscopy. Although only a few
cells were ﬂuorescent in normal-glucose and high-manni-
Normal
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FIG. 4. Altered pAkt staining pattern in diabetic human corneal epithelium. Human corneal frozen sections from patients with type 1 diabetes
(IDDM) and non–insulin-dependent type 2 diabetes (NIDDM), with normal subjects and diet-controlled type 2 diabetic patients as the control
subjects, were stained by immunoﬂuorescence with antibody against pAkt. Photos show merged images of immunoreactivity of pAkt and nuclear
staining of DAPI. Scale bar  50 m. (A high-quality digital representation of this ﬁgure is available in the online issue.)
FIG. 5. Weakening of wound induced EGFR signaling pathways in
human corneal epithelial cells cultured in high glucose. THCE cells
were cultured in normal glucose (NG; 5 mmol/l D-glucose) and high
glucose (HG; 25 mmol/l D-glucose) for 48 h and starved overnight in
keratinocyte basal medium with the same glucose conditions as before.
Cells were wounded extensively by sequence comb scratching (W) at
the indicated times (N, without wound). Cells were then lysed, and
equal amounts of proteins of 10–30 g were subjected to Western blot
using antibodies against phosphorylated proteins pAkt, pERK1/2, or
pEGFR (Y
845,- Y
1,068). After stripping off the immunoreactivities, the
membranes were reprobed with antibody against Akt, ERK2, or EGFR,
respectively, for proper protein loading. As each condition was pro-
cessed separately for Western blotting, each comparison between the
control and treated samples were made only within each group.
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of ﬂuorescent cells after 24 h culture. Furthermore, the
production of ROS induced by high glucose was sensitive
to antioxidant present in the culture medium because
NAC, a nonspeciﬁc ROS scavenger, attenuated ROS gen-
eration in THCE cells cultured in high glucose for 24 h
(Fig. 6C). HB-EGF, on the other hand, exhibited no effects
on ﬂuorescence-positive cells in high-glucose–cultured
cells with or without NAC (data not shown).
Antioxidants in combination with an EGFR ligand
enhanced ex vivo corneal epithelial wound closure.
Having demonstrated that the antioxidant NAC suppresses
high-glucose–induced ROS generation in human corneal
epithelial cells, we next investigated whether high-glu-
cose–delayed epithelial wound closure could be reversed
by antioxidants. We previously showed that HB-EGF ac-
celerates epithelial wound healing in normal corneas (29).
Hence, we ﬁrst tested the effects of HB-EGF and NAC on
epithelial wound closure in cultured porcine corneas.
Unlike HB-EGF, NAC alone had no effect on wound
healing of corneas cultured in either normal or high
glucose (data not shown). Although both HB-EGF and
NAC noticeably accelerated epithelial wound closure, the
rate of closure in high-glucose–cultured corneas in the
presence of HB-EGF or NAC was not signiﬁcantly higher
than that in the absence of HB-EGF or NAC (Fig. 7).
Remarkably, the presence of both HB-EGF (50 ng/ml) and
the antioxidant NAC (25 mol/l) resulted in signiﬁcantly
accelerated wound healing with a rate similar to that
observed in corneas cultured in normal glucose (P  0.01)
(Fig. 7B). This accelerated wound healing was sensitive to
the presence of BSO, which inhibits the generation of
intracellular glutathione. Hence, we conclude that EGFR
activation alone may not be sufﬁcient for restoring corneal
epithelial wound healing impaired by high glucose, and
antioxidants may serve as adjunctive therapy to EGFR
ligands for treating diabetic keratopathy.
Effects of antioxidants on EGFR, ERK, and PI
3-kinase/Akt phosphorylation in porcine corneas
cultured in high glucose. The effects of high glucose on
ex vivo corneal epithelial wound healing were dramatic
and highly reproducible. To elucidate the underlying
mechanisms for antioxidants to affect epithelial wound
closure, we assessed the signaling pathways in healing
epithelial cells of porcine corneas cultured in normal and
high glucose with or without antioxidants. Figure 8 shows
that whereas high glucose appeared to increase ERK
activation, phosphorylation of Akt was reduced in high-
glucose–cultured cells. Addition of HB-EGF or NAC in
high-glucose culture media restored partially high-glu-
cose–impaired Akt phosphorylation. Consistent with
greater acceleration of high-glucose–impaired wound clo-
sure, a combination of HB-EGF and NAC in high-glucose–
cultured porcine corneas also enhanced wound-induced
Akt phosphorylation to a larger extent than either HB-EGF
or NAC acting individually. NAC appeared to have some
effects on ERK phosphorylation as well because NAC
treatment increased the levels of p-ERK in migrating cells
in cultured pig corneas. Taken together, our results sug-
gest that high glucose may affect EGFR signaling, partic-
ularly the PI 3-kinase/Akt pathway, through elevated ROS,
a process that can be reversed by the antioxidant NAC
(35,36).
FIG. 6. Overproduction of ROS in cultured primary human corneal
epithelial cells. Primary human corneal epithelial cells were cultured in
medium containing normal glucose (NG), high glucose (HG), or high
mannitol (HM) or medium with BSO (250 mol/l) as positive control
for 24 h and then incubated with cell-permeable DCFH-DA (5 mol/l)
for 45 min. A: Cells were detached by trypsin digestion and washed with
PBS. Fluorescence of oxidized DCFH-DA by intracellular ROS was
detected by ﬂow cytometry for quantitative measurement. Fluores-
cence peaks in normal glucose, high mannitol, or high glucose were
compared in terms of DCF-positive (DCF) cells relative to the cells
with nonﬂuorescence peak on the left. B: The mean ﬂuorescence
intensity of ﬂow cytometry was quantiﬁed as the means  SD. *P <
0.05. C: THCE cells were grown in normal glucose, high mannitol, or
high glucose with or without NAC for 24 h and incubated with
DCFH-DA as mentioned above. ROS generation was visualized under a
ﬂuorescent microscope. Scale bar  50 m. (A high-quality digital
representation of this ﬁgure is available in the online issue.)
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In this study, we investigated the effects of high glucose on
corneal epithelial wound healing. We showed that high
glucose delayed epithelial wound closure in cultured por-
cine corneas and impaired both basal and wound-induced
PI 3-kinase/Akt signaling pathway. Hyperglycemia-induced
impairment of the PI 3-kinase/Akt pathway was also
apparent in the corneal epithelium of diabetic patients, but
not in the age-matched nondiabetic control subjects. When
human corneal epithelial cells were exposed to high
glucose for 48 h, their response to wounding was blunted
in terms of the duration and intensity of EGFR phosphor-
ylation and of Akt and ERK activation. The downregulated
cell signaling was related to oxidative stress because
antioxidant NAC prevented high-glucose–targeted impair-
ment of PI 3-kinase/Akt signaling in cultured corneas.
Furthermore, the addition of HB-EGF was unable to
overcome the inhibitory effects of high glucose on corneal
epithelial wound healing, whereas the presence of both
the antioxidant and EGFR ligand greatly accelerated
wound healing in cultured porcine corneas. Taken to-
gether, we conclude that oxidative stress induced by high
glucose weakens EGFR signaling and suppresses the PI
3-kinase/Akt pathway, resulting in the impairment of epi-
thelial wound healing in diabetes corneas.
In the literature, both in vitro and animal models of type
1 and type 2 diabetes have been used to study diabetic
corneal complications and wound healing, and a wealth
of information has been obtained from these studies
(7,9,25,37–42). For example, hyperglycemia was found to
decrease cell proliferation but have no effects on apoptosis
and necrosis (43) in the corneal epithelium of streptozo-
tocin-induced diabetic rats, leading to decreased cell den-
sity and increased intercellular spaces (44), characteristics
of diabetic keratopathy. However, the limitation in tissue
size of diseased animals such as rats has hampered the
biochemical analysis of hyperglycemia-induced alterations
in the cornea. As for the in vitro studies, discrepant results
have been reported regarding the effects of high glucose
on human corneal epithelial cell proliferation; whereas
McDermott et al. (40) reported that high glucose (17.5
mmol/l) increases cell proliferation, Fujita et al. (39)
showed a decrease in cell proliferation in the presence of
high glucose. Organ culture represents a more relevant
experimental approach compared with cultured cells (45–
47). Using human corneas, Kabosova et al. (8) showed that
organ-cultured human corneas from diabetic retinopathy
patients exhibited much-delayed epithelial wound healing,
in complete accordance with clinical data in diabetic
patients. Moreover, the corneas of patients in organ cul-
ture preserved the same marked abnormalities and altered
expression of proteinase and growth factors as in vivo
corneas. We previously used cultured porcine corneas as
an ex vivo model to study epithelial wound healing and
showed that healing an epithelial wound requires EGFR
and its downstream signaling pathways, notably ERK and
PI 3-kinase/Akt (29). Interestingly, high glucose induced a
highly reproducible and marked delay in epithelial wound
healing in cultured porcine corneas, similar to that ob-
served in patients and in cultured human corneas (8),
validating the porcine corneal organ culture system as a
valuable ex vivo model to study the effects of high glucose
on corneal wound healing. It should be mentioned that
Zagon et al. (48) reported that there was no abnormality in
corneal reepithelialization after epithelial debridement
within the ﬁrst 2 weeks of streptozotocin-induced diabetes
in rats. The reason for the discrepancy in the results of in
FIG. 7. Effects of HB-EGF and NAC on corneal epithelial wound healing
in high-glucose conditions. A: Representative epithelial wound closure
in cultured porcine corneas. A corneal epithelial wound of 5-mm
diameter was made and allowed to heal in MEM containing normal
glucose (NG; 5 mmol/l D-glucose) and in high glucose (HG; 25 mmol/l
D-glucose) alone or in the presence of HB-EGF (HG-HB; 50 ng/ml), with
(HG-HB-NAC) or without NAC (HG-NAC; 25 mol/l) and BSO (HG-HB-
NAC-BSO; 250 mol/l) for 48 h, followed by Richardson staining to
show the remaining wound. B: Remaining wound area after 48 hours.
Changes in the means of the remaining wound area in pixels were
analyzed by ANOVA. Data are the means  SD of at least six corneas
from three independent experiments. **P < 0.01. Scale bar  5 mm. H,
high; N, normal. (A high-quality digital representation of this ﬁgure is
available in the online issue.)
FIG. 8. Antioxidant NAC restored high-glucose–impaired PI 3-kinase/
Akt pathway in cultured porcine corneas. Porcine corneas with 5-mm
diameter epithelial wounds were cultured in MEM containing normal
glucose (NG) and in high glucose (HG) in the presence of HB-EGF (HB)
with (HBN) or without NAC for 48 h. Epithelial cells from two
representative corneas per group (n  6) were collected by scraping
cells off of the cultured corneas and lysed at the end of the culture.
Equal amounts of cell lysate were immunoblotted with antibodies
against tyrosine-phosphorylated Akt or ERK1/2. The same membranes
were stripped off the immunoreactivities and reprobed with Akt or
ERK2, respectively, for equal protein loading.
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corneas) is not clear and may be related to the lack of
neuronal nourishment in cultured corneas. Indeed, the
combination of substance P and IGF-I has been shown to
promote delayed corneal epithelial wound healing in dia-
betic rats (49). The neurological protection against corneal
diabetic complications is of great interest and should be
further explored in ex vivo studies and in animal models.
Whereas the described keratopathy/epitheliopathy can be
attributed in part to defects in epithelium–basement mem-
brane adhesion and to diabetic corneal neuropathy
(17,18), we propose that many epithelial defects and
abnormalities may also be related to alterations in EGFR
signaling in the epithelial cells themselves.
Unlike cancerous epithelial cells, there are very few
reports regarding EGFR signaling in diabetic tissues/cells.
Although a dramatic decrease in hepatic EGFR transcripts
was observed during the progression of diabetes (50), type
2 diabetic mice were shown to have upregulated EGFR
and elevated EGFR phosphorylation, which were sus-
pected to play a role in kidney enlargement in diabetes
(51). In diabetic glomeruli and in mesangial cells treated
with high glucose, elevated Akt phosphorylation, through
the EGFR/PI 3-kinase pathway, was shown to mediate
high-glucose–induced collagen I upregulation (52). On the
other hand, high glucose speciﬁcally downregulates Akt
activities in endothelial cells (53,54) and endothelial pro-
genitor cells (35,36), and disruption of Akt pathways has
been linked to endothelial dysfunction and diabetic com-
plications, both macro- and microvascular (55). Thus, the
effects of hyperglycemia on the PI 3-kinase/Akt pathway
may be tissue-/cell type–speciﬁc.
Our study was the ﬁrst to show that high glucose is
speciﬁcally targeting PI 3-kinase in corneal epithelial cells.
Interestingly, 48-h exposure to high glucose did not signif-
icantly affect another major EGFR-mediated signaling
pathway, the ERK pathway, in either normal unwounded
controls or in healing corneal epithelial cells. Our previous
studies revealed that the basal and wound-induced ERK
and Akt phosphorylation/activation are EGFR dependent,
and those pathways are required for epithelial wound
healing in corneal epithelial cells (34). Hence, high-
glucose–mediated impairment of the PI 3-kinase/Akt path-
way may contribute to delayed wound healing in porcine
corneas cultured in high glucose. Most strikingly, we
observed a severely altered staining pattern of p-Akt in the
corneas of both insulin-dependent and insulin-indepen-
dent diabetic patients compared with that of age-matched
normal subjects. Our data suggest a direct correlation
between hyperglycemia and p-Akt expression/distribution
in the human corneas. Because PI 3-kinase and Akt have
been shown to control diverse cellular activities, including
cell survival, growth, proliferation, metabolism, and migra-
tion (56), low Akt activity induced by hyperglycemia may
be a contributing factor to abnormalities such as basal cell
degeneration (6), decreased cell proliferation (9), and,
more importantly, the delayed epithelial wound healing
(8,9,57) observed in diabetic corneas.
Oxidative stress caused by hyperglycemia is important
for the development of diabetic abnormalities (23,24). In
addition to being an avascular and transparent tissue, the
cornea is unique in that it is constantly exposed to and
absorbs most of the harmful UV light. Therefore, a strong,
intrinsic defense mechanism against oxidative stress must
exist in corneal epithelial cells. Two enzymes, aldehyde
dehydrogenase 3 (58,59) and transketolase (60,61), abun-
dantly expressed in corneal epithelial cells have been
suggested to function as “corneal crystallins.” They play a
protective role against UV-induced oxidative stress
through the generation of antioxidant NADPH, the scav-
enging of ROS, and/or the possession of chaperone-like
activity (62). Nevertheless, severe abnormalities, including
epithelial cell damage in the corneas of diabetic patients
(7,8), suggest the dysfunction of intracellular antioxidant
apparatus induced by hyperglycemia. To that end, we used
DCFH-DA as a probe for intracellular oxidative stress and
showed that high glucose increased levels of DCFH in
cultured primary human corneal epithelial cells and in the
number of ﬂuorescent cells in THCE cell culture. The
notion that high glucose increases in oxidative stress was
further afﬁrmed by the detection of a decrease in cellular
glutathione levels, an indicator of cellular antioxidant
capacity, in porcine corneal epithelial cells cultured in
high glucose and by the observation that L-buthionine
sulfoximine, an inhibitor of glutathione synthesis, reversed
the effects of NAC on restoring high-glucose–delayed
epithelial wound healing. The latter observation also sug-
gests that depletion of the intracellular glutathione con-
tents may be an underlying mechanism for hyperglycemia-
induced oxidative stress in diabetic cornea. Taken
together, our data suggest that oxidative stress may also
be a cause of diabetic keratopathy and contribute to the
delay of epithelial wound healing in diabetic corneas.
The observation that the antioxidant NAC partially
reversed high-glucose–induced suppression of Akt phos-
phorylation suggests that the generated ROS is a contrib-
uting factor for high-glucose–induced disruption of the PI
3-kinase/Akt signaling pathway. As such, it is possible that
the Akt pathway may be particularly sensitive to oxidative
stress, as shown in culture bovine retinal (63) and human
umbilical vein (53) endothelial cells. In the literature,
oxidative stress has been shown to target p85 of PI
3-kinase (63), tumor suppressor PTEN (phosphatase and
tensin homolog deleted on chromosome 10) (53), or
inositol 5-phosphatase SHIP2 (SH2-containing inositol 5-
phosphatase 2) (64), all of which inﬂuence Akt activation
and signaling. Which molecule(s) in the PI 3-kinase/Akt
pathway might be the target of high-glucose–induced
oxidative stress in the diabetic cornea is under investiga-
tion in our laboratories.
Because delays in epithelial wound healing may result in
sight-threatening complications and increase the possibil-
ity of microbial infections in diabetic patients with an
already weakened immune system (2,57), efforts have
been made to identify reagents that accelerate epithelial
wound healing in diabetic corneas (57). Growth factors
such as EGF (65,66), insulin (9), and antioxidants such as
trolox (25) have been tested in animal models and were
shown to have limited success in managing diabetic
wound healing. Using corneal organ culture, we showed
that HB-EGF or NAC alone does not effectively restore the
high-glucose–delayed epithelial wound healing. However,
treatment of high-glucose–cultured corneas with a combi-
nation of antioxidant and HB-EGF restored the rate of
wound closure to a level close to that of corneas cultured
in normal glucose. Hence, HB-EGF elevating EGFR signal-
ing and antioxidants such as NAC reducing oxidative
stress may have synergistic effects on epithelial cells and
therefore may prevent or reverse epithelial defects, includ-
ing compromised barrier function and delayed wound
healing, in diabetic corneas. The unique feature of treating
diabetic keratopathy is with the use of topical application
K.-P. XU AND ASSOCIATES
DIABETES, VOL. 58, MAY 2009 1083of therapeutics. Hence, further studies aimed at under-
standing how aberrant EGFR signaling, including PI
3-kinase/Akt pathways and enhanced production of ROS
by hyperglycemia, results in diabetic corneal defects and
complications should provide the molecular basis for
developing better combinational therapies to treat diabetic
corneal complications, including delayed epithelial wound
healing.
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